Systemic Lupus Erythematosus with neuropsychiatric manifestations in a child: case report and review of the international recommendations for the diagnostics and management

The article describes a clinical case of a teenage girl with systemic lupus erythematosus with neuropsychiatric manifestations. The overview part describes modern approaches to the diagnosis and treatment of children with systemic lupus erythematosus with central nervous system lesions. The authors describe actual Russian and international clinical recommendations, they pay particular attention to the imperfection and inconsistency of classifications, differences in terminological systems, and the features of the rheumatologists’ and psychiatrists’ clinical practice. They provide the recommendations on the correct diagnosis wording in children with neuropsychiatric symptoms as a part of autoimmune disease. The article substantiates the necessity of an interdisciplinary approach and the cooperation of pediatric rheumatologists, psychiatrists, neurologists, clinical psychologists.

1. Carreño L., López-Longo F.J., Monteagudo I., Rodríguez-Mahou M., Bascones M., González C.M. et al. Immunological and clinical differences between juvenile and adult onset of systemic lupus erythematosus. Lupus 1999; 8(4): 287–292. DOI: 10.1191/096120399678847786

2. Ramírez Gómez L.A., Uribe Uribe O., Osio Uribe O., Grisales Romero H., Cardiel M.H., Wojdyla D. et al. Childhood systemic lupus erythematosus in Latin America. Lupus 2008; 17(6): 596–604. DOI: 10.1177/0961203307088006

3. Yu H.H., Lee J.H., Wang L.C., Yang Y.H., Chiang B.L. Neuropsychiatric manifestations in pediatric systemic lupus erythematosus: a 20-year study. Lupus 2006; 15(10): 651–657. DOI: 10.1177/0961203306070990

4. Groot N., Graeff N., Avcin T., Bader-Meunier B., Brogan P., Dolezalova P. et al. European evidence-based recommendations for diagnosis and treatment of childhood-onset systemic lupus erythematosus: the SHARE initiative Ann Rheum Dis 2017; 76(11): 1788–1796. DOI: 10.1136/annrheumdis-2016-210960

5. Briani C., Lucchetta M., Ghirardello A., Toffanin E., Zampieri S., Ruggero S. et al. Neurolupus is associated with anti-ribosomal P protein antibodies: an inception cohort study. J Autoimmun 2009; 32(2): 79–84. DOI: 10.1016/j.jaut.2008.12.002

6. Petri M., Magder L. Classification criteria for systemic lupus erythematosus: a review. Lupus 2004; 13(11): 829–837. DOI: 10.1191/0961203304lu2019oa

7. Petri M., Orbai A.M., Alarcón G.S. Gordon C., Merrill J. T., Fortin P. R. et al. Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus. Arthrit Rheumatol 2012; 64(8): 2677–2686. DOI: 10.1002/art.34473

8. Federal Clinical Guidelines for the Care of Children with Systemic Lupus Erythematosus. http://astgmu.ru/wp-content/uploads/2018/10/DETYAM-S-SISTEMNOJ-KRASNOJ-VOLCHANKOJ.pdf. (in Russ.)

9. Alexeeva E.I., Dvoryakovskaya T.M., Nikishina I.P., Denisova R.V., Podchernyaeva N.S., Sukhorukikh O.A. et al. Systemic Lupus Erythematosus: Clinical Recommendations. Part 1. Voprosy sovremennoi pediatrii 2018; 17(1): 19–37. (in Russ.)

10. The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes. Arthritis Rheum 1999; 42(4): 599–608. DOI: 10.1002/1529-0131(199904)42:4<599::AID-ANR2>3.0.CO;2-F

11. ICD-10 – International Statistical Classification of Diseases. https://mkb-10.com (in Russ.)

12. Clinical recommendations for the diagnosis and treatment of organic mental disorders in childhood https://minzdrav. gov-murman.ru/documents/poryadki-okazaniya-meditsinskoy-pomoshchi/2249.pdf. (in Russ.)

13. Tiganov A.S., Snezhnevskij A.V., Orlovskaja D.D., Koljaskina G.I., Koncevoj V.A., Kopejko G.I. et al. Psychiatry Guide. V. 2 Moscow: Meditsina, 1999; 784. (in Russ.)

14. Bertsias G., Ioannidis J.P., Boletis J., Bollen E., Bombardieri S., Bruce I.N. et al. EULAR recommendations for the management of systemic lupus erythematosus. Report of a Task Force of the EULAR standing Committee for International clinical studies including therapeutics. Ann Rheum Dis 2008; 67(2): 195–205. DOI: 10.1136/ard.2010.130476

15. Chau S.Y., Mok C.C. Factors predictive of corticosteroid psychosis in patients with systemic lupus erythematosus. Neurology 2003; 61(1): 104–107. DOI: 10.1212/wnl.61.1.104

16. Ainiala H., Dastidar P., Loukkola J., Lehtimäki T., Korpela M., Peltola J. et al. Cerebral MRI abnormalities and their association with neuropsychiatric manifestations in SLE: a population-based study. Scand J Rheumatol 2005; 34(5): 376–382. DOI: 10.1080/03009740510026643

17. Vega-Fernandez P., Vanderburgh White S., Zelko F., Ruth N.M., Levy D.M., Muscal E. et al. Cognitive Performance scores for the Pediatric Automated Neuropsychological Assessment Metrics in Childhood-Onset systemic lupus erythematosus. Arthritis Care Res 2015; 67(8):1119–1127. DOI: 10.1002/acr.22571

18. Harrison M. J., Morris K. A., Horton R., Toglia J., Barsky J., Chait S. et al. Results of intervention for lupus patients with self-perceived cognitive difficulties. Neurology 2005; 65(8): 1325–1327. DOI: 10.1212/01.wnl.0000180938.69146.5e

19. Greco C.M., Rudy T.E., Manzi S. Effects of a stress-reduction program on psychological function, pain, and physical function of systemic lupus erythematosus patients: a randomized controlled trial. Arthritis Rheum 2004; 51(1): 625–634. DOI: 10.1002/art.20533